Arcturus Therapeutics Holdings (ARCT) Enterprise Value (2018 - 2025)
Arcturus Therapeutics Holdings' Enterprise Value history spans 8 years, with the latest figure at -$230.9 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 20.93% year-over-year to -$230.9 million; the TTM value through Dec 2025 reached -$230.9 million, up 20.93%, while the annual FY2025 figure was -$230.9 million, 20.93% up from the prior year.
- Enterprise Value reached -$230.9 million in Q4 2025 per ARCT's latest filing, up from -$235.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$230.9 million in Q4 2025 to a low of -$466.8 million in Q1 2021.
- Average Enterprise Value over 5 years is -$322.2 million, with a median of -$317.5 million recorded in 2022.
- Peak YoY movement for Enterprise Value: crashed 684.99% in 2021, then surged 42.57% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$370.5 million in 2021, then decreased by 5.77% to -$391.9 million in 2022, then grew by 11.45% to -$347.0 million in 2023, then increased by 15.84% to -$292.0 million in 2024, then grew by 20.93% to -$230.9 million in 2025.
- Per Business Quant, the three most recent readings for ARCT's Enterprise Value are -$230.9 million (Q4 2025), -$235.4 million (Q3 2025), and -$251.5 million (Q2 2025).